| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > So What Do You Value in Your Team? |
|
Digg It - So What Do You Value in Your Team?
Think about yourself and your will think about others. That is, if you are teaming up with colleagues or with According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product friends. But what do you value? And what does this mean for your contribution to the team. But first things f ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rst; what do I value? Pleasure for example. Work is not the best place to look for pleasure, but that does no lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t mean that activities should be boring. Make sure that you get some fun in the team, it certainly increases t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e team spirit. A sense of duty is required to do a job, but it is even more important in a team. Hopefully ot d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hers values this as much as you do, but that does not automatically (re) solve the team results. This is also ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc lose to another attribute: responsibility. Promotion is a very current value in organizations but will not al easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ways help the team. It is an individual value and exclusive for only part of the team. If too many colleagues nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically alue promotion you should be careful. Taking risks is an individual value but could also be attributed to the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ team if most members value this equally. Taking risks is needed to innovate and requires a culture that suppo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ts making mistakes. But too much risks will destabilize the team. Stability is however a value that is often a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a vailable. Both values taking risks and stability should be balanced in the team. Cooperation is a value which dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod is easily defined but hard to "manage". If you value cooperation you will have to subordinate your personal ob cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin jectives with those of the team. Competition is the opponent of cooperation. And again both values should be e tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ually present in the team. Without competition there will be no pressure, too much competition will destabiliz t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e the team. There are many other values of which appreciation is normally undervalued. It is a special kind t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust at has two faces; the demand side and the supply side. If you are in the team make sure you appreciate the oth y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products er members ... not focusing on their personality, but on their input. Take a moment and think about these val . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de es and improve your team results. If you want to know more, just check this link =>elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip p://www.astorwhite.com/What_do_I_value.php">http://www.astorwhite.com/What_do_I_value.php © 2006 Hans Boo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Increase the Size of Donor Gifts with Fundraising Letters Have You Successfully Anchored Your Sales Associations: You Could Be Losing Millions
|